Search research articles
Contact Us
Filters
Showing results (151-160 of 220) with videos related to
Page
of 22
Sort By:
Frontiers in Cellular Neuroscience
|
August 16, 2018
PolyQ Tract Toxicity in SCA1 is Length Dependent in the Absence of CAG Repeat Interruption
Suran Nethisinghe, Maria Lucia Pigazzini, Sally Pemble, et al.
Biochimica Et Biophysica Acta
|
May 24, 1995
Mitochondrial DNA (mtDNA) diseases: correlation of genotype to phenotype
J A Morgan-Hughes, M G Sweeney, J M Cooper, et al.
Cancer Chemotherapy and Pharmacology
|
July 13, 2005
Sequential administration of irinotecan and cytarabine in the treatment of relapsed and refractory acute myeloid leukemia
Hans Minderman, Kieran L O'Loughlin, Patrick F Smith, et al.
Journal of the Neurological Sciences
|
January 1, 1992
Evidence for intramitochondrial complementation between deleted and normal mitochondrial DNA in some patients with mitochondrial myopathy
S R Hammans, M G Sweeney, I J Holt, et al.
Brain : a Journal of Neurology
|
June 1, 1993
The mitochondrial DNA transfer RNA(Lys)A-->G(8344) mutation and the syndrome of myoclonic epilepsy with ragged red fibres (MERRF). Relationship of clinical phenotype to proportion of mutant mitochondrial DNA
S R Hammans, M G Sweeney, M Brockington, et al.
Hearing, Balance and Communication
|
June 4, 2016
The frequency of the m.1555A>G (<i>MTRNR1</i>) variant in UK patients with suspected mitochondrial deafness
Peter Kullar, Charlotte L Alston, Sarah Ball, et al.
Diabetes
|
November 15, 2000
Activation of p38 mitogen-activated protein kinase alpha and beta by insulin and contraction in rat skeletal muscle: potential role in the stimulation of glucose transport
R Somwar, M Perreault, S Kapur, et al.
Neurology
|
January 2, 2008
What causes paramyotonia in the United Kingdom? Common and new SCN4A mutations revealed
E Matthews, S V Tan, D Fialho, et al.
Forensic Science International
|
August 23, 2001
External quality assessment of laboratory performance in analysis of toxicological cases
J F Wilson, P A Toseland, N E Capps, et al.
Therapeutic Drug Monitoring
|
June 19, 1998
An audit of therapeutic drug monitoring service provision by laboratories participating in an external quality assessment scheme
A H Thomson, I D Watson, J F Wilson, et al.
Page
of 22
Search research articles
Search
Showing results (151-160 of 220) with videos related to
Sort By:
Page
of 22
Frontiers in Cellular Neuroscience
|
August 16, 2018
PolyQ Tract Toxicity in SCA1 is Length Dependent in the Absence of CAG Repeat Interruption
Suran Nethisinghe, Maria Lucia Pigazzini, Sally Pemble, et al.
Biochimica Et Biophysica Acta
|
May 24, 1995
Mitochondrial DNA (mtDNA) diseases: correlation of genotype to phenotype
J A Morgan-Hughes, M G Sweeney, J M Cooper, et al.
Cancer Chemotherapy and Pharmacology
|
July 13, 2005
Sequential administration of irinotecan and cytarabine in the treatment of relapsed and refractory acute myeloid leukemia
Hans Minderman, Kieran L O'Loughlin, Patrick F Smith, et al.
Journal of the Neurological Sciences
|
January 1, 1992
Evidence for intramitochondrial complementation between deleted and normal mitochondrial DNA in some patients with mitochondrial myopathy
S R Hammans, M G Sweeney, I J Holt, et al.
Brain : a Journal of Neurology
|
June 1, 1993
The mitochondrial DNA transfer RNA(Lys)A-->G(8344) mutation and the syndrome of myoclonic epilepsy with ragged red fibres (MERRF). Relationship of clinical phenotype to proportion of mutant mitochondrial DNA
S R Hammans, M G Sweeney, M Brockington, et al.
Hearing, Balance and Communication
|
June 4, 2016
The frequency of the m.1555A>G (<i>MTRNR1</i>) variant in UK patients with suspected mitochondrial deafness
Peter Kullar, Charlotte L Alston, Sarah Ball, et al.
Diabetes
|
November 15, 2000
Activation of p38 mitogen-activated protein kinase alpha and beta by insulin and contraction in rat skeletal muscle: potential role in the stimulation of glucose transport
R Somwar, M Perreault, S Kapur, et al.
Neurology
|
January 2, 2008
What causes paramyotonia in the United Kingdom? Common and new SCN4A mutations revealed
E Matthews, S V Tan, D Fialho, et al.
Forensic Science International
|
August 23, 2001
External quality assessment of laboratory performance in analysis of toxicological cases
J F Wilson, P A Toseland, N E Capps, et al.
Therapeutic Drug Monitoring
|
June 19, 1998
An audit of therapeutic drug monitoring service provision by laboratories participating in an external quality assessment scheme
A H Thomson, I D Watson, J F Wilson, et al.
Page
of 22